


| Key | % Net Assets |
|---|---|
| 5.6% | |
| 3.5% | |
| 3.2% | |
| 2.5% | |
| 85.2% |
| Name | % Net Assets |
|---|---|
| Exxon Mobil | 5.6% |
| Microsoft | 3.5% |
| Johnson & Johnson | 3.2% |
| Pfizer | 2.5% |
| Intel | 2.3% |
| General Electric | 2.3% |
| ConocoPhillips | 2.1% |
| Monsanto | 2.0% |
| Lilly (Eli) | 2.0% |
| Medtronic | 1.9% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 1,583.00p |
| Currency | GBP |
| Change | -5.00p |
| % | -0.31% |
| YTD change | 75.00p |
| YTD % | 4.97% |
| Fund Inception | 15/10/1984 |
|---|---|
| Fund Manager | Erik Rubingh |
| TER | 0.79 (30-Apr-2011) |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | £25,000 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 1.00% |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.03 |
You are here: research